A director at Medpace Holdings Inc sold 39,342 shares at 404.764USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Old National Named Among the 50 Most Community-Minded Companies in the U.S. Points of Light Program ‘The Civic 50’ Recognizes Top Companies for Corporate Citizenship, Social Impact and Community Engagement EVANSVILLE, Ind., May 16, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (“Old National”) has been named by Points of Light as one of “The Civic 50” honorees for 2024 – a list that recognizes the 50 most community-minded companies in the nation. A global nonprofit organization that inspires, equips and mobilizes millions of people to take action that changes the world, Points of Light...
Old National Bancorp Announces Quarterly Dividends EVANSVILLE, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (the “Company” or “Old National”) (NASDAQ: ONB) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This quarterly cash dividend will be payable on June 17, 2024, to shareholders of record as of the close of business on June 5, 2024. In addition, the Board of Directors declared a quarterly cash dividend of $17.50 per share (equivalent to $0.4375 per depositary share or ...
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update MORRISVILLE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today reported financial results for the first quarter ended March 31, 2024. The company will host a webcast at 8:30 a.m. ET on May 14, 2024 to discuss the financial results and provide a corporate update. Dr. Roger Jeffs, Liquidia’s chief executive officer, said: “We continue to vigorously pursue final agency action for YUTREPIA’s approval for pulmonary arterial hypertension (PAH) and pulmonary hypertens...
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam $126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.Over 735 Patients Have Completed a Phase 3 Trial of Simufilam. AUSTIN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial results for first quarter ended March 31, 2024. Net income was $25.0 million compared to a net loss o...
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to the investigational use of L606 (liposomal treprostinil) inhalation suspension in people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) at the American Thoracic Society (AT...
Moody's Ratings (Moody's) today affirmed Starbucks Corporation's ("Starbucks") ratings, including its Baa1 senior unsecured ratings and Prime-2 short-term commercial paper rating. The outlook remains stable. The affirmation and stable outlook reflect Moody's expectation that Starbucks' financial p...
AVENTURA, Fla.--(BUSINESS WIRE)-- Immersion Corporation (Nasdaq: IMMR), a leading developer and provider of technologies for haptics, today reported financial results for the first quarter ended March 31, 2024. First Quarter Financial Summary1: Total revenues of $43.8 million, compared to $7.1 million in the first quarter of 2023. GAAP net income was $18.7 million, or $0.59 per diluted share, compared to GAAP net income of $8.3 million, or $0.25 per diluted share, in the first quarter of 2023. GAAP operating expenses of $27.2 million in the first quarter of 2024, compared to $3.8 mi...
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution Gross Proceeds from Warrants Represents the Sale of Approximately 5.7 Million Shares Of Common Stock At $22.00 Per Share AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”), a biotechnology company focused on Alzheimer’s disease, today announced total gross proceeds of over $125 million from cash-exercises of warrants that were previously distributed to its shareholders (the “Warrants”). Gross proceeds from the Warrants represents the issuance of approximately ...
Chris McDermott Joins Meridian Bank as SVP, Commercial Lending MALVERN, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Meridian Bank announced the appointment of Christopher E. McDermott to the position of Senior Vice President, Commercial Lending. He’ll join other members of the Meridian Commercial Lending Team in serving business customers in Bucks and Montgomery Counties. Chris began his long banking career right out of high school. He started as a clerk at Girard Bank and advanced through that organization while he simultaneously earned his degree in finance from LaSalle College. Moving from ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.